Investigation of L-carnitine effects on CD44 ⁺ cancer stem cells from MDA-MB-231 breast cancer cell line as anti-cancer therapy.

Autor: Farahzadi R; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Sanaat Z; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Movassaghpour-Akbari AA; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Fathi E; Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran., Montazersaheb S; Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Publikováno v: Regenerative therapy [Regen Ther] 2023 Jul 14; Vol. 24, pp. 219-226. Date of Electronic Publication: 2023 Jul 14 (Print Publication: 2023).

Acellular Wharton's Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation.

Autor: Talebi M; Department of Applied Cell Sciences, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Nozad Charoudeh H; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Movassaghpour Akbari AA; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Baradaran B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Kazemi T; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Publikováno v: Advanced pharmaceutical bulletin [Adv Pharm Bull] 2020 Sep; Vol. 10 (4), pp. 617-622. Date of Electronic Publication: 2020 Aug 09.

The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia.

Autor: Saraei R; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Division of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Soleimani M; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran., Movassaghpour Akbari AA; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Farshdousti Hagh M; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Hassanzadeh A; Department of Immunology, Division of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Solali S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: ssolali@gmail.com.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2018 Nov; Vol. 107, pp. 1010-1019. Date of Electronic Publication: 2018 Aug 24.

Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.

Autor: Shali H; a Tuberculosis and Lung Disease Research Center , Tabriz University of Medical Sciences , Tabriz , Iran.; b Student's Research Committee , Tabriz University of Medical Sciences , Tabriz , Iran., Shabani M; c Department of Immunology, School of Medicine , Shahid Beheshti University of Medical Sciences , Tehran , Iran., Pourgholi F; d Department of Immunology , Tabriz University of Medical Sciences , Tabriz , Iran., Hajivalili M; d Department of Immunology , Tabriz University of Medical Sciences , Tabriz , Iran., Aghebati-Maleki L; d Department of Immunology , Tabriz University of Medical Sciences , Tabriz , Iran., Jadidi-Niaragh F; a Tuberculosis and Lung Disease Research Center , Tabriz University of Medical Sciences , Tabriz , Iran., Baradaran B; d Department of Immunology , Tabriz University of Medical Sciences , Tabriz , Iran., Movassaghpour Akbari AA; e Hematology and Oncology Research Center , Tabriz University of Medical Sciences , Tabriz , Iran., Younesi V; f Pishtaz Teb Diagnostics , Tehran , Iran.; g Faculty of Paramedical Sciences , Alborz University of Medical Sciences , Karaj , Iran., Yousefi M; h Liver and Gastrointestinal Diseases Research Center , Tabriz University of Medical Sciences , Tabriz , Iran.; i Department of Immunology, School of Medicine , Tabriz University of Medical Sciences , Tabriz , Iran.

Publikováno v: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2018 Mar; Vol. 46 (2), pp. 293-302. Date of Electronic Publication: 2017 Mar 31.

Reliability Evaluation of Fluorescence In Situ Hybridization (FISH) and G-Banding on Bone Marrow and Peripheral Blood Cells in Chronic Myelogenous Leukemia Patients.

Autor: Manaflouyan Khajehmarjany S; Department of Cellular and Molecular Biology, Islamic Azad University, Ahar Branch, East Azerbaijan, Iran ; Dr. Rahmani Medical Genetic Lab, Tabriz, East Azerbaijan, Iran., Rahmani SA; Department of Cellular and Molecular Biology, Islamic Azad University, Ahar Branch, East Azerbaijan, Iran ; Dr. Rahmani Medical Genetic Lab, Tabriz, East Azerbaijan, Iran., Chavoshi SH; Department of Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran ; Emam Reza Hospital, Tabriz, East Azerbaijan, Iran., Esfahani A; Department of Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran ; Emam Reza Hospital, Tabriz, East Azerbaijan, Iran., Movassaghpour Akbari AA; Department of Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran ; Emam Reza Hospital, Tabriz, East Azerbaijan, Iran.

Publikováno v: Cell journal [Cell J] 2015 Spring; Vol. 17 (1), pp. 171-80. Date of Electronic Publication: 2015 Apr 08.